Additionally, HNSCC patients who received chemoradiotherapy had lower LETM1 expression (57.3%, 67/117) compared with those who had not received chemoradiotherapy (81.4%, 48/59) (P = 0.002). This evidence concerns the gene LETM1 and head and neck squamous cell carcinoma.